| Treatment group (n = 50) | Control group (n = 45) | P value |
---|---|---|---|
Number of SAEs within 1- month of enrollment (n) | 24 | 13 | 0.17* |
Median (Q1, Q3) | 2.0 (1.0, 6.0) | 1.0 (1.0, 4.0) | Â |
Number of SAEs within 3- months of enrollment (n) | 29 | 17 | 0.18* |
Median (Q1, Q3) | 2.0 (1.0, 8.0) | 1.0 (1.0, 7.0) | Â |
Number of SAEs within 12- months of enrollment (n) | 34 | 24 | 0.16* |
Median (Q1, Q3) | 2.0 (1.0, 13.0) | 1.5 (1.0, 9.0) | Â |
SAEs: Serious adverse events *Wilcoxon rank sum p value. |  |  |  |